AUA: Testicular Cancer Incidence Up Through 2009

This article originally appeared here.
Share this content:
AUA: Incidence of Testicular Cancer Up Through 2009
AUA: Incidence of Testicular Cancer Up Through 2009

(HealthDay News) -- The incidence of testicular germ cell tumors (TGCT) increased from 1992 to 2009, especially among Hispanic men, according to research presented at the annual meeting of the American Urological Association, held from May 4 to 8 in San Diego.

Manas Nigam, from the University of Chicago Pritzker School of Medicine, and colleagues examined trends in incidence of TGCT by race, ethnicity, and tumor characteristics from 1992 to 2009 using data extracted from the Surveillance, Epidemiology, and End Results-13 registry.

The researchers found that from 1992 to 2009 there was a significant annual percentage change (1.1%) in the incidence of TGCT among U.S. males over the age of 15 years. The rates of TGCT were highest for non-Hispanic white men and lowest for non-Hispanic black men. Incidence rates increased significantly for non-Hispanic white men (1.2%), and more prominent increases were observed for Hispanic men, especially from 2002 to 2009 (5.6%). The incidence of localized TGCTs and metastatic TGCTs increased significantly (1.21% and 1.43%, respectively). Non-Hispanic white men experienced increased incidence in localized tumors (1.56%), while for Hispanic men, increases were noted in localized (2.6%), regionalized (16.5% from 2002 to 2009), and distant (2.6%) tumors.

"More research is needed to shed light on why the incidence is up nationwide and if any environmental factors or comorbidities impact disease formation," Jeff Holzbeierlein, M.D., from the University of Kansas Medical Center in Kansas City, said in a statement. "These new data confirm Hispanic Americans should speak with their doctor about risk factors and be even more vigilant with their testicular health."

More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs